Picture of Cambridge Cognition Holdings logo

COG Cambridge Cognition Holdings Share Price

0.000.00%
gb flag iconLast trade - 00:00
TechnologySpeculativeMicro CapSucker Stock

Momentum

Relative Strength (%)
1m-3.94%
3m-29.67%
6m-25.01%
1yr-63.71%
Volume Change (%)
10d/3m-21.98%
Price vs... (%)
52w High-60.56%
50d MA-11.55%
200d MA-27.43%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-101.35%
Return on Equity-509.14%
Operating Margin-24.45%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Cambridge Cognition Holdings EPS forecast chart

Profile Summary

Cambridge Cognition Holdings plc is a United Kingdom-based company, which is engaged in developing and marketing digital solutions to assess brain health, principally in the United Kingdom, the United States and Europe. Its products include CANTAB, Electronic Clinical Outcomes Assessment (eCOA), NeuroVocalix, Winterlight, Cognition Kit, Clinpal, eConsent, and AQUA. CANTAB Connect gives the control to manage and deliver battery of touchscreen and voice assessments, as well as fully customizable electronic questionnaires and scales. The Company’s therapeutic areas include attention deficit hyperactivity disorder (ADHD), Alzheimer’s Disease, Autism Spectrum Disorder, Cognitive Safety, Core Cognitive Function, Depression, Down’s Syndrome, Drug Abuse Liability, Epilepsy, Huntington’s Disease, Multiple Sclerosis, Neuromuscular Disorders, Obsessive Compulsive Disorder, Parkinson’s Disease, Schizophrenia, Stroke and Cerebrovascular Disease, and Traumatic Brain Injury.

Directors

Last Annual
December 31st, 2023
Last Interim
December 31st, 2023
Incorporated
September 12th, 2012
Public Since
April 18th, 2013
No. of Employees
119
Sector
Software & IT Services
Industry
Technology
Exchange
gb flag iconLondon Stock Exchange
Shares in Issue
41,710,429

COG Share Price Performance

Latest News for COG

Upcoming Events for COG

Cambridge Cognition Holdings PLC Annual Shareholders Meeting

Cambridge Cognition Holdings PLC Annual Shareholders Meeting

Half Year 2024 Cambridge Cognition Holdings PLC Earnings Release

Similar to COG

Picture of 1Spatial logo

1Spatial

gb flag iconLondon Stock Exchange

Picture of 4Global logo

4Global

gb flag iconLondon Stock Exchange

Picture of accesso Technology logo

accesso Technology

gb flag iconLondon Stock Exchange

Picture of Activeops logo

Activeops

gb flag iconLondon Stock Exchange

Picture of Acuity RM logo

Acuity RM

gb flag iconLondon Stock Exchange

FAQ